455 related articles for article (PubMed ID: 30979844)
1. New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease.
Brassington K; Selemidis S; Bozinovski S; Vlahos R
Clin Sci (Lond); 2019 Apr; 133(7):885-904. PubMed ID: 30979844
[TBL] [Abstract][Full Text] [Related]
2. Oxidative Stress in Ozone-Induced Chronic Lung Inflammation and Emphysema: A Facet of Chronic Obstructive Pulmonary Disease.
Wiegman CH; Li F; Ryffel B; Togbe D; Chung KF
Front Immunol; 2020; 11():1957. PubMed ID: 32983127
[TBL] [Abstract][Full Text] [Related]
3. Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities.
Bernardo I; Bozinovski S; Vlahos R
Pharmacol Ther; 2015 Nov; 155():60-79. PubMed ID: 26297673
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease and COPD: dangerous liaisons?
Rabe KF; Hurst JR; Suissa S
Eur Respir Rev; 2018 Sep; 27(149):. PubMed ID: 30282634
[TBL] [Abstract][Full Text] [Related]
5. Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeutics.
Brassington K; Selemidis S; Bozinovski S; Vlahos R
Clin Sci (Lond); 2022 Mar; 136(6):405-423. PubMed ID: 35319068
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Obstructive Sleep Apnoea Syndrome and Overlap Syndrome.
Voulgaris A; Archontogeorgis K; Steiropoulos P; Papanas N
Curr Vasc Pharmacol; 2021; 19(3):285-300. PubMed ID: 32188387
[TBL] [Abstract][Full Text] [Related]
7. Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.
Tse HN; Tseng CZ
Int J Chron Obstruct Pulmon Dis; 2014; 9():825-36. PubMed ID: 25125976
[TBL] [Abstract][Full Text] [Related]
8. Statins in the treatment of COPD and asthma-where do we stand?
So JY; Dhungana S; Beros JJ; Criner GJ
Curr Opin Pharmacol; 2018 Jun; 40():26-33. PubMed ID: 29334676
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Markers of Inflammation and Oxidative Stress in COPD Patients with or without Cardiovascular Comorbidities.
Kaźmierczak M; Ciebiada M; Pękala-Wojciechowska A; Pawłowski M; Nielepkowicz-Goździńska A; Antczak A
Heart Lung Circ; 2015 Aug; 24(8):817-23. PubMed ID: 25797323
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease.
Biswas S; Hwang JW; Kirkham PA; Rahman I
Curr Med Chem; 2013; 20(12):1496-530. PubMed ID: 22963552
[TBL] [Abstract][Full Text] [Related]
11. Activation of angiotensin II type-2 receptor protects against cigarette smoke-induced COPD.
Mei D; Tan WSD; Liao W; Heng CKM; Wong WSF
Pharmacol Res; 2020 Nov; 161():105223. PubMed ID: 33017650
[TBL] [Abstract][Full Text] [Related]
12. Ergosterol attenuates cigarette smoke extract-induced COPD by modulating inflammation, oxidative stress and apoptosis
Sun X; Feng X; Zheng D; Li A; Li C; Li S; Zhao Z
Clin Sci (Lond); 2019 Jul; 133(13):1523-1536. PubMed ID: 31270147
[TBL] [Abstract][Full Text] [Related]
13. Defining the relationship between COPD and CVD: what are the implications for clinical practice?
Morgan AD; Zakeri R; Quint JK
Ther Adv Respir Dis; 2018; 12():1753465817750524. PubMed ID: 29355081
[TBL] [Abstract][Full Text] [Related]
14. Novel aspects of pathogenesis and regeneration mechanisms in COPD.
Bagdonas E; Raudoniute J; Bruzauskaite I; Aldonyte R
Int J Chron Obstruct Pulmon Dis; 2015; 10():995-1013. PubMed ID: 26082624
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk in chronic obstructive pulmonary disease.
Maclay JD; McAllister DA; Macnee W
Respirology; 2007 Sep; 12(5):634-41. PubMed ID: 17875049
[TBL] [Abstract][Full Text] [Related]
16. Endothelial Cells: From Dysfunction Mechanism to Pharmacological Effect in Cardiovascular Disease.
Haybar H; Shahrabi S; Rezaeeyan H; Shirzad R; Saki N
Cardiovasc Toxicol; 2019 Feb; 19(1):13-22. PubMed ID: 30506414
[TBL] [Abstract][Full Text] [Related]
17. COPD and stroke: are systemic inflammation and oxidative stress the missing links?
Austin V; Crack PJ; Bozinovski S; Miller AA; Vlahos R
Clin Sci (Lond); 2016 Jul; 130(13):1039-50. PubMed ID: 27215677
[TBL] [Abstract][Full Text] [Related]
18. Effects of imperatorin in the cardiovascular system and cancer.
Nasser MI; Zhu S; Hu H; Huang H; Guo M; Zhu P
Biomed Pharmacother; 2019 Dec; 120():109401. PubMed ID: 31622950
[TBL] [Abstract][Full Text] [Related]
19. Targeting oxidant-dependent mechanisms for the treatment of respiratory diseases and their comorbidities.
Thomson NC
Curr Opin Pharmacol; 2018 Jun; 40():1-8. PubMed ID: 29223018
[TBL] [Abstract][Full Text] [Related]
20. Role of beta-blockers in patients with COPD: current perspective.
Malerba M; Montuschi P; Radaeli A; Pirisi M
Drug Discov Today; 2015 Jan; 20(1):129-35. PubMed ID: 25238736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
